{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:16:19Z","timestamp":1770678979279,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T00:00:00Z","timestamp":1433030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10157-015-1130-2","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T15:28:33Z","timestamp":1432999713000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis"],"prefix":"10.1007","volume":"20","author":[{"given":"Tamehachi","family":"Namikoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuichi","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Fueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohachi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshisuke","family":"Haruna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yorimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Ihoriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Itano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,31]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, The Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900\u201320.","journal-title":"Am J Gastroenterol."},{"key":"1130_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1440-1746.2004.03521.x","volume":"20","author":"Y Fujiwara","year":"2005","unstructured":"Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Nishikawa H, Arakawa T. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"1130_CR3","first-page":"75","volume":"15","author":"JE Anderson","year":"1999","unstructured":"Anderson JE, Yim KB, Crowell MD. Prevalence of gastroesophageal reflux disease in peritoneal dialysis and hemodialysis patients. Adv Perit Dial. 1999;15:75\u20138.","journal-title":"Adv Perit Dial"},{"key":"1130_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MEG.0b013e3283200047","volume":"21","author":"H Strid","year":"2009","unstructured":"Strid H, Fjell A, Simren M, Bjornsson ES. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure. Eur J Gastroenterol Hepatol. 2009;21:137\u201342.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1130_CR5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/ndt\/17.8.1434","volume":"17","author":"H Strid","year":"2002","unstructured":"Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant. 2002;17:1434\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1130_CR6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","volume":"135","author":"PJ Kahrilas","year":"2008","unstructured":"Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, Johnson SP, Allen J, Brill JV. American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383\u201391.","journal-title":"Gastroenterology"},{"key":"1130_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","volume":"100","author":"KR DeVault","year":"2005","unstructured":"DeVault KR, Castell DO. American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190\u2013200.","journal-title":"Am J Gastroenterol"},{"key":"1130_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00044011-200424010-00001","volume":"24","author":"K Rohss","year":"2004","unstructured":"Rohss K, Wilder-Smith C, Naucler E, Jansson L. Esomeprazole 20\u00a0mg provides more effective intragastric acid control than maintenance-dose rabeprazole, lansoprazole or pantoprazole in healthy volunteers. Clin Drug Invest. 2004;24:1\u20137.","journal-title":"Clin Drug Invest"},{"key":"1130_CR9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cgh.2006.03.006","volume":"4","author":"KR Devault","year":"2006","unstructured":"Devault KR, Johanson JF, Johnson DA, Liu S, Sostek MB. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams. Clin Gastroenterol Hepatol. 2006;4:852\u20139.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1130_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2036.2006.03221.x","volume":"25","author":"V Norris","year":"2007","unstructured":"Norris V, Baisley K, Dunn K, Warrington S, Morocutti A. Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers. Aliment Pharmacol Ther. 2007;25:501\u201310.","journal-title":"Aliment Pharmacol Ther"},{"key":"1130_CR11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/11530810-000000000-00000","volume":"29","author":"RJ Hoogendoorn","year":"2009","unstructured":"Hoogendoorn RJ, Groeneveld L, Kwee JA. Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study. Clin Drug Invest. 2009;29:803\u201310.","journal-title":"Clin Drug Invest"},{"key":"1130_CR12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2036.2006.02774.x","volume":"23","author":"SJV Zanten van","year":"2006","unstructured":"van Zanten SJV, Chiba N, Armstrong D, Barkun AN, Thomson AB, Mann V, Escobedo S, Chakraborty B, Nevin K. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006;23:521\u20139.","journal-title":"Aliment Pharmacol Ther."},{"key":"1130_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-6-12","volume":"6","author":"KR Kulich","year":"2008","unstructured":"Kulich KR, Madisch A, Pacini F, Piqu\u00e9 JM, Regula J, Van Rensburg CJ, Ujsz\u00e1szy L, Carlsson J, Halling K, Wiklund IK. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12.","journal-title":"Health Qual Life Outcomes."},{"key":"1130_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00535-007-2098-9","volume":"42","author":"M Hongo","year":"2007","unstructured":"Hongo M, Kinoshita Y, Shimozuma K, Kumagai Y, Sawada M, Nii M. Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn. J Gastroenterol. 2007;42:807\u201315.","journal-title":"J Gastroenterol"},{"key":"1130_CR15","first-page":"296","volume":"40","author":"NE Montemurro","year":"1993","unstructured":"Montemurro NE, Di Maggio A, Loperfido A, Franceschi M, Scatizzi A. Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study. Clin Nephrol. 1993;40:296\u20138.","journal-title":"A preliminary study. Clin Nephrol."},{"key":"1130_CR16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1046\/j.1365-2036.1999.00669.x","volume":"13","author":"DA Revicki","year":"1999","unstructured":"Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1621\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"1130_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-230X-11-15","volume":"11","author":"S Yoshida","year":"2011","unstructured":"Yoshida S, Nii M, Date M. Effects of omeprazole on symptoms and quality of life in Japanese patients with reflux esophagitis: final results of OMAREE, a large-scale clinical experience investigation. BMC Gastroenterol. 2011;11:15.","journal-title":"BMC Gastroenterol."},{"key":"1130_CR18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2036.2011.04774.x","volume":"34","author":"A Becher","year":"2011","unstructured":"Becher A, El-Serag H. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:618\u201327.","journal-title":"Aliment Pharmacol Ther"},{"key":"1130_CR19","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1572-0241.2002.05772.x","volume":"97","author":"AH Cekin","year":"2002","unstructured":"Cekin AH, Boyacioglu S, Gursoy M, Bilezikci B, Gur G, Akin ED, Ozdemir N, Yilmaz U. Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: multivariate analysis of pathogenetic factors. Am J Gastroenterol. 2002;97:1352\u20136.","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1130-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-015-1130-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1130-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:44:45Z","timestamp":1559126685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-015-1130-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,31]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s10157-015-1130-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,31]]}}}